Nobuhiko Seki

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan

Shigeaki Suzuki, Nobuhisa Ishikawa, Fumie Konoeda et al. · Neurology · 2017 · 380 citations

Phase II Trial of Amrubicin for Treatment of Refractory or Relapsed Small-Cell Lung Cancer: Thoracic Oncology Research Group Study 0301

Sayaka Onoda, Noriyuki Masuda, Takashi Seto et al. · Journal of Clinical Oncology · 2006 · 226 citations

Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer

Takashi Seto, Masahiko Higashiyama, Hiroko Funai et al. · Lung Cancer · 2006 · 161 citations

Angiogenesis, Kdr Receptors, Medicine +9

Alteration of circulating type 2 follicular helper T cells and regulatory B cells underlies the comorbid association of allergic rhinitis with bronchial asthma

Ryuta Kamekura, Katsunori Shigehara, Satsuki Miyajima et al. · Clinical Immunology · 2015 · 114 citations · Full text